Impact of ixekizumab on facial psoriasis and related quality of life measures in moderate-to-severe psoriasis patients: 12-week results from two phase III trials.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Carle Paul Howard Sofen |
| Publication date | October 6, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |